BioNTech SE is 2.7x more valuable than BIO-TECHNE Corp by market capitalization ($21.79 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | BNTX |
|---|---|---|
| Market cap | $8.22 B | $21.79 B |
| US-listed rank | #1055 | #587 |
| Revenue (latest FY) | $1.22B | - |
| Net income (latest FY) | $73.40M | - |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 112.0 | - |
| SEC filings | 1,229 | 548 |
BioNTech SE is 2.7x more valuable than BIO-TECHNE Corp by market capitalization ($21.79 B vs $8.22 B).
Full pages: BIO-TECHNE Corp and BioNTech SE, or browse the full rankings.